Latest JudgementBharatiya Nagarik Suraksha Sanhita (BNSS), 2023

Aashish Verma v Union of India through Narcotics Control Bureau, Amritsar Zonal Unit, 2026

It highlights judicial caution in evaluating bail petitions in complex narcotics offences involving layered arrangements or intermediaries.

Punjab and Haryana High Court·18 February 2026
Aashish Verma v Union of India through Narcotics Control Bureau, Amritsar Zonal Unit, 2026
Bharatiya Nagarik Suraksha Sanhita (BNSS), 2023
Share:

Judgement Details

Court

Punjab and Haryana High Court

Date of Decision

18 February 2026

Judges

Justice Sumeet Goel

Citation

Acts / Provisions

Section 13(1)(ia), Hindu Marriage Act, 1955

Section 25, Hindu Marriage Act, 1955

Facts of the Case

  • The case arose from a massive seizure of over 1.37 crore psychotropic tablets weighing 5772.584 kg, including Alprazolam, Tramadol, and Zolpidem Tartrate.

  • Eight connected regular bail petitions were filed by accused persons, including directors and proprietors of licensed pharmaceutical companies.

  • Petitioners argued:

    • They operated through licensed pharmaceutical entities.

    • No illegal sale had occurred; all transactions were to licensed distributors.

    • Investigation was complete, no further recovery was pending, and prolonged incarceration served no purpose.

    • Mandatory provisions of the NDPS Act for grant of bail were not complied with.

  • NCB countered:

    • Huge commercial quantity recovered.

    • Petitioners implicated via disclosure statements of co-accused and subsequent recoveries.

    • Some accused admitted to procuring and distributing psychotropic medicines through medical stores.

    • Section 37 NDPS Act bars bail for commercial quantity offences.

  • The High Court emphasized that commercial sophistication or licences cannot shield from criminal accountability, especially in cases of organised diversion into illicit channels.

Issues

  1. Whether the petitioners are entitled to regular bail under Section 37 of the NDPS Act despite operating through licensed pharmaceutical entities?

  2. Whether the existence of licences or corporate structures negates prima facie inferences of organised diversion of narcotics?

  3. Whether commercial sophistication can serve as a defense against criminal accountability in large-scale narcotics cases?

  4. Whether the magnitude of seized contraband and involvement of intermediaries justifies the rejection of bail?

  5. Whether the court can examine legality of commercial transactions at the stage of regular bail?

Held

  • All regular bail petitions dismissed.

  • Section 37 NDPS Act applies, barring grant of bail due to commercial quantity seizure.

  • Mere existence of licences or corporate structure does not protect from prima facie inferences of organised diversion.

  • Commercial sophistication is not a shield against criminal accountability.

  • Investigation completion or lack of direct recovery does not justify grant of bail in large-scale NDPS offences.

Analysis

  • Reinforces the principle that NDPS Act’s Section 37 imposes strict restrictions on bail for commercial quantity offences.

  • Emphasizes that organised diversion of regulated pharmaceuticals cannot be masked by licences or corporate structures.

  • Highlights judicial caution in evaluating bail petitions in complex narcotics offences involving layered arrangements or intermediaries.

  • Confirms that prima facie evidence of organised diversion suffices to deny bail, even if direct recovery from petitioners is not made.

  • Strengthens accountability of pharmaceutical companies and their directors in cases of narcotic substance diversion.

  • Affirms that discretionary power of bail is narrower where commercial quantity and organised crime are involved.